期刊文献+

人肝细胞系L02胰岛素抵抗细胞模型的建立及鉴定 被引量:11

ESTABLISHMENT AND IDENTIFICATION OF INSULIN-RESISTANT L02 CELL MODEL INDUCED WITH INSULIN
下载PDF
导出
摘要 [目的]采用高浓度胰岛素体外诱导培养法建立人肝细胞IR模型,为研究IR的发生发展机制及筛选改善IR的药物提供一种简便可靠的IR细胞模型。[方法]以人肝细胞系L02为研究对象,在含5×10-7 mol/L人胰岛素的培养液培养16 h,未用高浓度胰岛素培养者为对照组。之后两组分别加入0、1、10、50、100、200 ng/ml人胰岛素。采用葡萄糖氧化酶-过氧化物酶法(GOD-POD)法检测培养液中残存葡萄糖含量。[结果]在各浓度的胰岛素刺激下,高胰岛素诱导组培养液中残存葡萄糖含量均显著高于对照细胞(P﹤0.01)。[结论]用含5×10-7 mol/L胰岛素的培养液培养16 h的L02细胞产生胰岛素抵抗,作为IR肝细胞模型可广泛用于胰岛素抵抗的研究。 [Objective]To establish an convenient and reliable insulin-resistant cell model of human liver cell with high concentration insulin,which can be used for the study of insulin-resistant mechanisms and the screening of medicine.[Methods]L02 cells in experimental group were incubated in culture solution containing 5×10-7 mol/L insulin for 16 hours,while L02 cells in control group were incubated without insulin.Then 0 ng/ml、1 ng/ml、10 ng/ml、50 ng/ml、100 ng/ml、200 ng/ml insulin separately were added in culture solution of two groups.The content of glucose remained in L02 cells culture solution was measured by the method of glucose oxidizes peroxides(GOD-POD).[Results]The content of glucose remained in culture solution added with high concentration of insulin in experimental group was notably higher than that in control group(P﹤0.01).[Conclusions]The L02 cells which are incubated in culture solution with high concentration of insulin(5×10-7 mol/L)have insulin-resistance.The IR liver cell model can be widely used for the study of insulin resistance.
出处 《现代预防医学》 CAS 北大核心 2007年第22期4233-4234,4236,共3页 Modern Preventive Medicine
基金 重庆医科大学创新基金(CX0528)
关键词 L02 胰岛素抵抗 细胞模型 L02 Insulin resistance Cell model
  • 相关文献

参考文献3

二级参考文献36

  • 1周播江,钟翠平,顾云娣,张新华,梁春敏,吴超群.肝再生大鼠血清诱导骨髓干细胞向肝细胞分化的实验研究[J].中华肝脏病杂志,2004,12(12):730-733. 被引量:35
  • 2Yun-Wen Zheng,Nobuhiro Ohkohchi,Hideki Taniguchi.Quantitative evaluation of long-term liver repopulation and the reconstitution of bile ductules after hepatocellular transplantation[J].World Journal of Gastroenterology,2005,11(39):6176-6181. 被引量:9
  • 3Gurnell M,Savage DB,Chatterjee VK et al.The metabolic syndrome:Peroxisome proliferator-activated receptor gamma and its therapeutic modulation[J].J Clin Endocrinol Metab,2003,88(6):2412-21.
  • 4Tadayyon M,Smith SA.Insulin sensitisation in the treatment of Type diabetes[J].Expert Opin Investig Drugs,2003,12(3):307-24.
  • 5Melin B,Cherqui G,Blivet MJ et al.Dual effect of metformin in cultured rat hepatocytes:potentiation of insulin action and prevention of insulin-induced insulin resistance[J].Metabolism,1990,39:1089.
  • 6Arakawa K,Ishihara T,Auto M et al.Action of novel antidiabetic thiazolidinedione,T-174,in animals of non-insulin-dependent diabetes mellitus(NIDDM) and in cultured muscle cells[J].Br J Pharmacol,1998,125:429-36.
  • 7Senn JJ,Klover PJ,Nowak IA et al.Interleukin-6 induces cellular insulin resistance in hepatocytes[J].Diabetes,2002,51(12):3391-9
  • 8Bernal MC,Weng S,Finck BN et al.Dexamethasone induction of hypertension and diabetes is PPAR-alpha dependent in LDL receptor-null mice[J].Nat Med,2003,9(8):1069-75.
  • 9Camp HS.Thiazolidinediones in diabetes:Current status and future outlook[J].Curr Opin Investig Drugs,2003,4(4):406-11.
  • 10Santure M,Pitre M,Nadeau A et al.Effect of troglitazone on vascular and glucose metabolic actions of insulin in high-sucrose-fed rats[J].Metabolism,2003,52(8):978-86.

共引文献48

同被引文献117

引证文献11

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部